teclistamab,daratumumab,lenalidomide
genmab,janssen
['daratumumab', ' lena', 'mmsm', 'lenalidomide', 'multiple myeloma', 'teclistamab']
teclistamab plus daratumumab and lenalidomide produced deep and durable responses in patients with relapsed or refractory multiple myeloma. #ash22 #mmsm 
https://t.co/bi63MIVP5D is a resource offering oncology health care professionals practical information about the changing clinical landscape.